Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but ...

Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.

During each menstrual cycle phase, you can experience a range of emotions. This is because your hormones fluctuate throughout ...

PR Newswire LAS VEGAS, June 10, 2025 The growth hormone deficiency market is expected to see expansion across the 7MM driven by the introduction of innovative therapies, including ...

Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.